Viking Therapeutics, Inc. short interest in 2025
In 2025, Viking Therapeutics, Inc.'s disclosed short interest ran from 18.13% of shares outstanding on 15 Jan 2025 to 21.54% on 31 Dec 2025, a change of +3.41 percentage points. The year's high was 25.52% on 31 Jul 2025 and its low 18.13% on 15 Jan 2025, averaging 22.83% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 11.72 days on 31 Dec 2025. Full history: Viking Therapeutics, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2025 in figures
- Start of year
- 18.13% (15 Jan 2025)
- End of year
- 21.54% (31 Dec 2025)
- Change
- +3.41 pp
- High
- 25.52% (31 Jul 2025)
- Low
- 18.13% (15 Jan 2025)
- Average
- 22.83%
- Highest days to cover
- 11.72 (31 Dec 2025)
- SEC filings marked
- 8
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2025 | 18.13% | 6.46 | |
| 31 Jan 2025 | 21.32% | 6.26 | |
| 14 Feb 2025 | 22.37% | 5.14 | results (8-K) |
| 28 Feb 2025 | 21.30% | 3.82 | 10-K filed |
| 14 Mar 2025 | 21.57% | 4.79 | |
| 31 Mar 2025 | 22.82% | 8.53 | |
| 15 Apr 2025 | 22.67% | 4.77 | |
| 30 Apr 2025 | 23.63% | 5.84 | results (8-K), 10-Q filed |
| 15 May 2025 | 22.74% | 7.69 | |
| 30 May 2025 | 23.78% | 10.73 | |
| 13 Jun 2025 | 25.35% | 8.49 | |
| 30 Jun 2025 | 25.51% | 6.87 | |
| 15 Jul 2025 | 25.43% | 7.86 | |
| 31 Jul 2025 | 25.52% | 7.06 | 10-Q filed, results (8-K) |
| 15 Aug 2025 | 24.47% | 5.79 | |
| 29 Aug 2025 | 23.72% | 1.85 | |
| 15 Sep 2025 | 24.02% | 5.40 | |
| 30 Sep 2025 | 24.49% | 5.10 | |
| 15 Oct 2025 | 22.52% | 4.90 | |
| 31 Oct 2025 | 21.39% | 5.41 | results (8-K), 10-Q filed |
| 14 Nov 2025 | 21.93% | 5.40 | |
| 28 Nov 2025 | 20.34% | 7.77 | |
| 15 Dec 2025 | 21.26% | 8.78 | |
| 31 Dec 2025 | 21.54% | 11.72 |
See also: Viking Therapeutics, Inc.'s full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.